 | ODI | 表記: | OCTANE-1,8-DIOL | 組成式: | C8 H18 O2 | SMILES: | OCCCCCCCCO | InChi: | InChI=1S/C8H18O2/c9-7-5-3-1-2-4-6-8-10/h9-10H,1-8H2 | 別名: | 1,8-OCTANEDIOL | 定義日: | 2006-04-23 | 最終更新日: | 2020-06-17 | 識別子(ID): | octane-1,8-diol |
|
 | ODK | 表記: | 3-pyridin-2-yl-1H-pyrazole-5-carboxylic acid | 組成式: | C9 H7 N3 O2 | SMILES: | O=C(O)c1cc(nn1)c2ncccc2 | InChi: | InChI=1S/C9H7N3O2/c13-9(14)8-5-7(11-12-8)6-3-1-2-4-10-6/h1-5H,(H,11,12)(H,13,14) | 別名: | 5-Pyridin-2-yl-2H-pyrazole-3-carboxylic acid | 定義日: | 2010-08-12 | 最終更新日: | 2020-06-17 | 識別子(ID): | 3-(pyridin-2-yl)-1H-pyrazole-5-carboxylic acid |
|
 | ODT | 表記: | (11E,13E,15Z)-OCTADECA-11,13,15-TRIENOIC ACID | 組成式: | C18 H30 O2 | SMILES: | O=C(O)CCCCCCCCCC=CC=CC=C/CC | InChi: | InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-8H,2,9-17H2,1H3,(H,19,20)/b4-3-,6-5+,8-7+ | 別名: | 11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID | 定義日: | 2005-10-24 | 最終更新日: | 2020-06-17 | 識別子(ID): | (11E,13E,15Z)-octadeca-11,13,15-trienoic acid |
|
 | OER | 表記: | SR-MN4-O5 CLUSTER | 組成式: | Mn4 O5 Sr | SMILES: | O1[Mn][O-]2|3[Mn]4|O5[Sr++]2|O6[Mn]1|3[O+]4[Mn]56 | InChi: | InChI=1S/4Mn.5O.Sr/q | 別名: | Mn4SrOt5-cluster | 定義日: | 2013-02-12 | 最終更新日: | 2020-06-17 |
|
 | OGK | 表記: | (1S,2S)-2-ethyl-1-({[(3aS,4S,6R,7aS)-6-ethyl-1-oxooctahydro-1H-inden-4-yl]carbonyl}amino)cyclopropanecarboxylic acid | 組成式: | C18 H27 N O4 | SMILES: | O=C(NC1(C(=O)O)CC1CC)C3CC(CC)CC2C(=O)CCC23 | InChi: | InChI=1S/C18H27NO4/c1-3-10-7-13-12(5-6-15(13)20)14(8-10)16(21)19-18(17(22)23)9-11(18)4-2/h10-14H,3-9H2,1-2H3,(H,19,21)(H,22,23)/t10-,11+,12+,13+,14+,18+/m1/s1 | 別名: | Coronatine | 定義日: | 2010-09-07 | 最終更新日: | 2020-06-17 | 識別子(ID): | (1S,2S)-2-ethyl-1-({[(3aS,4S,6R,7aS)-6-ethyl-1-oxooctahydro-1H-inden-4-yl]carbonyl}amino)cyclopropanecarboxylic acid |
|
 | OGN | 表記: | [(Z)-[(3R,4R,5R,6R)-3-acetamido-6-(hydroxymethyl)-4,5-bis(oxidanyl)oxan-2-ylidene]amino] N-phenylcarbamate | 組成式: | C15 H19 N3 O7 | SMILES: | O=C(ON=C1/OC(CO)C(O)C(O)C1NC(=O)C)Nc2ccccc2 | InChi: | InChI=1S/C15H19N3O7/c1-8(20)16-11-13(22)12(21)10(7-19)24-14(11)18-25-15(23)17-9-5-3-2-4-6-9/h2-6,10-13,19,21-22H,7H2,1H3,(H,16,20)(H,17,23)/b18-14-/t10-,11-,12+,13-/m1/s1 | 別名: | Gal-PUGNAc | 定義日: | 2011-09-22 | 最終更新日: | 2020-06-17 | 識別子(ID): | N-[(2Z,3R,4R,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-{[(phenylcarbamoyl)oxy]imino}tetrahydro-2H-pyran-3-yl]acetamide (non-preferred name) |
|
 | OHB | 表記: | salicylamide | 組成式: | C7 H7 N O2 | SMILES: | O=C(c1ccccc1O)N | InChi: | InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10) | 別名: | 2-hydroxybenzamide | 定義日: | 2013-04-10 | 最終更新日: | 2020-06-17 | 公開日: | 2013-10-09 | 識別子(ID): | 2-hydroxybenzamide |
|
 | OHW | 表記: | 4-[2-[(2~{R})-2-[3-propyl-6-(trifluoromethyloxy)-1~{H}-indol-2-yl]piperidin-1-yl]ethyl]morpholine | 組成式: | C23 H32 F3 N3 O2 | SMILES: | CCCc1c([nH]c2cc(OC(F)(F)F)ccc12)[CH]3CCCCN3CCN4CCOCC4 | InChi: | InChI=1S/C23H32F3N3O2/c1-2-5-19-18-8-7-17(31-23(24,25)26)16-20(18)27-22(19)21-6-3-4-9-29(21)11-10-28-12-14-30-15-13-28/h7-8,16,21,27H,2-6,9-15H2,1H3/t21-/m1/s1 | 別名: | CAD204520 | 定義日: | 2020-03-12 | 最終更新日: | 2020-06-17 | 公開日: | 2020-05-20 | 識別子(ID): | 4-[2-[(2~{R})-2-[3-propyl-6-(trifluoromethyloxy)-1~{H}-indol-2-yl]piperidin-1-yl]ethyl]morpholine |
|
 | OID | 表記: | 10-(1H-imidazol-1-yl)decanoic acid | 組成式: | C13 H22 N2 O2 | SMILES: | O=C(O)CCCCCCCCCn1ccnc1 | InChi: | InChI=1S/C13H22N2O2/c16-13(17)8-6-4-2-1-3-5-7-10-15-11-9-14-12-15/h9,11-12H,1-8,10H2,(H,16,17) | 別名: | 10-imidazolyl-decanoic acid | 定義日: | 2009-03-27 | 最終更新日: | 2020-06-17 | 識別子(ID): | 10-(1H-imidazol-1-yl)decanoic acid |
|
 | OIS | 表記: | (S)-N-((2S,3R)-3-HYDROXY-4-(4-((E)-(HYDROXYIMINO)METHYL)-N-ISOBUTYLPHENYLSULFONAMIDO)-1-PHENYLBUTAN-2-YL)-3-METHYL-2-(3
-((2-METHYLTHIAZOL-4-YL)METHYL)-2-OXOIMIDAZOLIDIN-1-YL)BUTANAMIDE | 組成式: | C34 H46 N6 O6 S2 | SMILES: | O=S(=O)(c1ccc(C=NO)cc1)N(CC(C)C)CC(O)C(NC(=O)C(N2C(=O)N(CC2)Cc3nc(sc3)C)C(C)C)Cc4ccccc4 | InChi: | InChI=1S/C34H46N6O6S2/c1-23(2)19-39(48(45,46)29-13-11-27(12-14-29)18-35-44)21-31(41)30(17-26-9-7-6-8-10-26)37-33(42)32(24(3)4)40-16-15-38(34(40)43)20-28-22-47-25(5)36-28/h6-14,18,22-24,30-32,41,44H,15-17,19-21H2,1-5H3,(H,37,42)/b35-18+/t30-,31+,32-/m0/s1 | 別名: | OXIMINOARYLSULFONAMIDE | 定義日: | 2005-02-11 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S)-N-{(1S,2R)-1-benzyl-2-hydroxy-3-[({4-[(E)-(hydroxyimino)methyl]phenyl}sulfonyl)(2-methylpropyl)amino]propyl}-3-methyl-2-{3-[(2-methyl-1,3-thiazol-4-yl)methyl]-2-oxoimidazolidin-1-yl}butanamide |
|
 | OLU | 表記: | 2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE | 組成式: | C10 H6 N2 O2 S2 | SMILES: | O=C1N=C(SC1)c2sc3c(n2)ccc(O)c3 | InChi: | InChI=1S/C10H6N2O2S2/c13-5-1-2-6-7(3-5)16-10(11-6)9-12-8(14)4-15-9/h1-3,13H,4H2 | 別名: | OXYLUCIFERIN | 定義日: | 2005-09-06 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-(6-hydroxy-1,3-benzothiazol-2-yl)-1,3-thiazol-4(5H)-one |
|
 | OLV | 表記: | cyclohexyl
[(2R,6S,12Z,13aS,14aR,16aS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14a-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,
16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-
yl]carbamate | 組成式: | C39 H52 N6 O9 S | SMILES: | C5(N1C(CC(C1)Oc3nc2c(ccc(c2)OC)nc3C)C(=O)NC7(C(NS(C4(CC4)C)(=O)=O)=O)C(C=CCCCCCC5NC(=O)OC6CCCCC6)C7)=O | InChi: | InChI=1S/C39H52N6O9S/c1-24-34(41-31-20-27(52-3)16-17-29(31)40-24)53-28-21-32-33(46)43-39(36(48)44-55(50,51)38(2)18-19-38)22-25(39)12-8-5-4-6-11-15-30(35(47)45(32)23-28)42-37(49)54-26-13-9-7-10-14-26/h8,12,16-17,20,25-26,28,30,32H,4-7,9-11,13-15,18-19,21-23H2,1-3H3,(H,42,49)(H,43,46)(H,44,48)/b12-8-/t25-,28-,30+,32+,39-/m1/s1 | 別名: | P4-6 (NR03-67) | 定義日: | 2019-06-28 | 最終更新日: | 2020-06-17 | 公開日: | 2020-03-04 | 識別子(ID): | cyclohexyl [(2R,6S,12Z,13aS,14aR,16aS)-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-14a-{[(1-methylcyclopropyl)sulfonyl]carbamoyl}-5,16-dioxo-1,2,3,5,6,7,8,9,10,11,13a,14,14a,15,16,16a-hexadecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecin-6-yl]carbamate |
|
 | OM7 | 表記: | (2R,6S,12Z,13aS,14aR,16aS)-6-[(N-acetyl-L-isoleucyl)amino]-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-N-[(1-methylcyclo
propyl)sulfonyl]-5,16-dioxo-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacycl
opentadecine-14a(5H)-carboxamide | 組成式: | C40 H55 N7 O9 S | SMILES: | C6(N3C(CC(Oc2c(nc1c(cc(OC)cc1)n2)C)C3)C(NC5(C(NS(C4(C)CC4)(=O)=O)=O)C(C5)C=CCCCCCC6NC(C(NC(C)=O)C(CC)C)=O)=O)=O | InChi: | InChI=1S/C40H55N7O9S/c1-7-23(2)33(42-25(4)48)35(50)43-30-14-12-10-8-9-11-13-26-21-40(26,38(52)46-57(53,54)39(5)17-18-39)45-34(49)32-20-28(22-47(32)37(30)51)56-36-24(3)41-29-16-15-27(55-6)19-31(29)44-36/h11,13,15-16,19,23,26,28,30,32-33H,7-10,12,14,17-18,20-22H2,1-6H3,(H,42,48)(H,43,50)(H,45,49)(H,46,52)/b13-11-/t23-,26+,28+,30-,32-,33-,40+/m0/s1 | 別名: | P4-P5-4 (AJ-65) | 定義日: | 2019-06-28 | 最終更新日: | 2020-06-17 | 公開日: | 2020-03-04 | 識別子(ID): | (2R,6S,12Z,13aS,14aR,16aS)-6-[(N-acetyl-L-isoleucyl)amino]-2-[(7-methoxy-3-methylquinoxalin-2-yl)oxy]-N-[(1-methylcyclopropyl)sulfonyl]-5,16-dioxo-1,2,3,6,7,8,9,10,11,13a,14,15,16,16a-tetradecahydrocyclopropa[e]pyrrolo[1,2-a][1,4]diazacyclopentadecine-14a(5H)-carboxamide |
|
 | ON3 | 表記: | 1-(4-{[(2S,3R)-2-(2,3-dihydro-1H-inden-2-yloxy)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]oxy}phenyl)cyclopropan
ecarboxylic acid | 組成式: | C31 H34 O7 | SMILES: | c1(cc(c(c(c1)OC)C)OC)C(C(COc2ccc(cc2)C3(C(O)=O)CC3)OC4Cc5c(C4)cccc5)O | InChi: | InChI=1S/C31H34O7/c1-19-26(35-2)16-22(17-27(19)36-3)29(32)28(38-25-14-20-6-4-5-7-21(20)15-25)18-37-24-10-8-23(9-11-24)31(12-13-31)30(33)34/h4-11,16-17,25,28-29,32H,12-15,18H2,1-3H3,(H,33,34)/t28-,29+/m0/s1 | 別名: | ONO-3080573 | 定義日: | 2015-03-31 | 最終更新日: | 2020-06-17 | 公開日: | 2015-06-03 | 識別子(ID): | 1-(4-{[(2S,3R)-2-(2,3-dihydro-1H-inden-2-yloxy)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]oxy}phenyl)cyclopropanecarboxylic acid |
|
 | ON7 | 表記: | {1-[(2S,3S)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]-4-(methoxycarbonyl)-1
H-pyrrol-3-yl}acetic acid | 組成式: | C30 H35 N O7 | SMILES: | O=C(c1c(cn(c1)CC(C(O)c2cc(OC)c(C)c(c2)OC)CC4Cc3ccccc3C4)CC(=O)O)OC | InChi: | InChI=1S/C30H35NO7/c1-18-26(36-2)12-22(13-27(18)37-3)29(34)24(11-19-9-20-7-5-6-8-21(20)10-19)16-31-15-23(14-28(32)33)25(17-31)30(35)38-4/h5-8,12-13,15,17,19,24,29,34H,9-11,14,16H2,1-4H3,(H,32,33)/t24-,29+/m0/s1 | 別名: | ONO9780307 | 定義日: | 2015-03-31 | 最終更新日: | 2020-06-17 | 公開日: | 2015-06-03 | 識別子(ID): | {1-[(2S,3S)-2-(2,3-dihydro-1H-inden-2-ylmethyl)-3-(3,5-dimethoxy-4-methylphenyl)-3-hydroxypropyl]-4-(methoxycarbonyl)-1H-pyrrol-3-yl}acetic acid |
|
 | OP1 | 表記: | 1-[(1S)-4-carbamimidamido-1-carboxybutyl]-5-oxo-D-proline | 組成式: | C11 H18 N4 O5 | SMILES: | O=C(O)C(N1C(=O)CCC1C(=O)O)CCCNC(=[N@H])N | InChi: | InChI=1S/C11H18N4O5/c12-11(13)14-5-1-2-6(9(17)18)15-7(10(19)20)3-4-8(15)16/h6-7H,1-5H2,(H,17,18)(H,19,20)(H4,12,13,14)/t6-,7+/m0/s1 | 別名: | Pyronopaline | 定義日: | 2014-02-28 | 最終更新日: | 2020-06-17 | 公開日: | 2014-10-22 | 識別子(ID): | 1-[(1S)-4-carbamimidamido-1-carboxybutyl]-5-oxo-D-proline |
|
 | OPD | 表記: | 9R,13R-12-OXOPHYTODIENOIC ACID | 組成式: | C18 H28 O3 | SMILES: | O=C1C=CC(CCCCCCCC(=O)O)C1C/C=C/CC | InChi: | InChI=1S/C18H28O3/c1-2-3-7-11-16-15(13-14-17(16)19)10-8-5-4-6-9-12-18(20)21/h3,7,13-16H,2,4-6,8-12H2,1H3,(H,20,21)/t15-,16-/m1/s1 | 別名: | 9R,13R-OPDA | 定義日: | 2001-04-06 | 最終更新日: | 2020-06-17 | 識別子(ID): | 8-[(1R,5R)-4-oxo-5-pent-2-en-1-ylcyclopent-2-en-1-yl]octanoic acid |
|
 | 7WF | 表記: | 2-hydroxy-3-[4-(2-hydroxy-3-sulfopropyl)piperazin-1-yl]propane-1-sulfonic acid | 組成式: | C10 H22 N2 O8 S2 | SMILES: | O[CH](CN1CCN(CC1)CC(O)C[S](O)(=O)=O)C[S](O)(=O)=O | InChi: | InChI=1S/C10H22N2O8S2/c13-9(7-21(15,16)17)5-11-1-2-12(4-3-11)6-10(14)8-22(18,19)20/h9-10,13-14H,1-8H2,(H,15,16,17)(H,18,19,20)/t9-,10?/m1/s1 | 別名: | POPSO | 定義日: | 2017-01-25 | 最終更新日: | 2020-06-17 | 公開日: | 2017-04-12 | 識別子(ID): | 2-oxidanyl-3-[4-[(2~{R})-2-oxidanyl-3-sulfo-propyl]piperazin-1-yl]propane-1-sulfonic acid |
|
 | OPY | 表記: | (3S)-4-oxo-4-piperidin-1-ylbutane-1,3-diamine | 組成式: | C9 H19 N3 O | SMILES: | O=C(N1CCCCC1)C(N)CCN | InChi: | InChI=1S/C9H19N3O/c10-5-4-8(11)9(13)12-6-2-1-3-7-12/h8H,1-7,10-11H2/t8-/m0/s1 | 別名: | GSK237826A | 定義日: | 2010-05-17 | 最終更新日: | 2020-06-17 | 識別子(ID): | (2S)-2,4-diamino-1-(piperidin-1-yl)butan-1-one |
|
 | OQR | 表記: | {(2R)-7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl}methanol | 組成式: | C14 H21 N3 O3 | SMILES: | C2Cc1cc(CO)c(cc1NC2CNC(C)C)[N+]([O-])=O | InChi: | InChI=1S/C14H21N3O3/c1-9(2)15-7-12-4-3-10-5-11(8-18)14(17(19)20)6-13(10)16-12/h5-6,9,12,15-16,18H,3-4,7-8H2,1-2H3/t12-/m1/s1 | 別名: | oxamniquine | 定義日: | 2015-06-11 | 最終更新日: | 2020-06-17 | 公開日: | 2015-09-30 | 識別子(ID): | {(2R)-7-nitro-2-[(propan-2-ylamino)methyl]-1,2,3,4-tetrahydroquinolin-6-yl}methanol |
|
 | ORE | 表記: | 4-(2,7-DIFLUORO-6-HYDROXY-3-OXO-3H-XANTHEN-9-YL)ISOPHTHALIC ACID | 組成式: | C21 H10 F2 O7 | SMILES: | O=C(O)c4ccc(C=1c3c(OC=2C=1C=C(F)C(=O)C=2)cc(O)c(F)c3)c(C(=O)O)c4 | InChi: | InChI=1S/C21H10F2O7/c22-13-4-11-17(6-15(13)24)30-18-7-16(25)14(23)5-12(18)19(11)9-2-1-8(20(26)27)3-10(9)21(28)29/h1-7,24H,(H,26,27)(H,28,29) | 別名: | OREGON GREEN 488 CARBOXYLATE | 定義日: | 2005-07-21 | 最終更新日: | 2020-06-17 | 識別子(ID): | 4-(2,7-difluoro-6-hydroxy-3-oxo-3H-xanthen-9-yl)benzene-1,3-dicarboxylic acid |
|
 | 7Z3 | 表記: | 1-(3-PYRROLIDIN-1-YLPHENYL)METHANAMINE | 組成式: | C11 H16 N2 | SMILES: | c1ccc(cc1CN)N2CCCC2 | InChi: | InChI=1S/C11H16N2/c12-9-10-4-3-5-11(8-10)13-6-1-2-7-13/h3-5,8H,1-2,6-7,9,12H2 | 別名: | CC38513 | 定義日: | 2011-12-08 | 最終更新日: | 2020-06-17 | 識別子(ID): | 1-[3-(pyrrolidin-1-yl)phenyl]methanamine |
|
 | OSB | 表記: | 2-SUCCINYLBENZOATE | 組成式: | C11 H10 O5 | SMILES: | O=C(O)c1ccccc1C(=O)CCC(=O)O | InChi: | InChI=1S/C11H10O5/c12-9(5-6-10(13)14)7-3-1-2-4-8(7)11(15)16/h1-4H,5-6H2,(H,13,14)(H,15,16) | 別名: | O-SUCCINYLBENZOATE | 定義日: | 2000-08-11 | 最終更新日: | 2020-06-17 | 識別子(ID): | 2-(3-carboxypropanoyl)benzoic acid |
|
 | 7ZU | 表記: | (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-5,6-dimethyl-6-oxidanyl-hept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydr
o-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol | 組成式: | C28 H44 O3 | SMILES: | C[CH](C=C[CH](C)C(C)(C)O)[CH]1CC[CH]2C(CCC[C]12C)=CC=C3C[CH](O)C[CH](O)C3=C | InChi: | InChI=1S/C28H44O3/c1-18(9-10-19(2)27(4,5)31)24-13-14-25-21(8-7-15-28(24,25)6)11-12-22-16-23(29)17-26(30)20(22)3/h9-12,18-19,23-26,29-31H,3,7-8,13-17H2,1-2,4-6H3/b10-9+,21-11+,22-12-/t18-,19+,23-,24-,25+,26+,28-/m1/s1 | 別名: | 1,25-dihydroxyvitamin D2 | 定義日: | 2017-02-28 | 最終更新日: | 2020-06-17 | 公開日: | 2017-05-10 | 識別子(ID): | (1~{R},3~{S},5~{Z})-5-[(2~{E})-2-[(1~{R},3~{a}~{S},7~{a}~{R})-1-[(~{E},2~{R},5~{S})-5,6-dimethyl-6-oxidanyl-hept-3-en-2-yl]-7~{a}-methyl-2,3,3~{a},5,6,7-hexahydro-1~{H}-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol |
|
 | 7ZV | 表記: | 5-hydroxydiclofenac | 組成式: | C14 H11 Cl2 N O3 | SMILES: | OC(=O)Cc1cc(O)ccc1Nc2c(Cl)cccc2Cl | InChi: | InChI=1S/C14H11Cl2NO3/c15-10-2-1-3-11(16)14(10)17-12-5-4-9(18)6-8(12)7-13(19)20/h1-6,17-18H,7H2,(H,19,20) | 別名: | 2-[2-[[2,6-bis(chloranyl)phenyl]amino]-5-oxidanyl-phenyl]ethanoic acid | 定義日: | 2016-12-13 | 最終更新日: | 2020-06-17 | 公開日: | 2017-02-08 | 識別子(ID): | 2-[2-[[2,6-bis(chloranyl)phenyl]amino]-5-oxidanyl-phenyl]ethanoic acid |
|